TG Therapeutics, Inc. vs Bausch Health Companies Inc.: Annual Revenue Growth Compared

Pharma Giants: A Decade of Revenue Growth Compared

__timestampBausch Health Companies Inc.TG Therapeutics, Inc.
Wednesday, January 1, 20148263500000152381
Thursday, January 1, 201510498800000152381
Friday, January 1, 20169674000000152381
Sunday, January 1, 20178724000000152381
Monday, January 1, 20188380000000152000
Tuesday, January 1, 20198601000000152000
Wednesday, January 1, 20208027000000152000
Friday, January 1, 202184340000006689000
Saturday, January 1, 202281240000002785000
Sunday, January 1, 20238757000000233662000
Loading chart...

Unveiling the hidden dimensions of data

A Tale of Two Companies: Revenue Growth from 2014 to 2023

In the dynamic world of pharmaceuticals, revenue growth is a key indicator of a company's success. Over the past decade, Bausch Health Companies Inc. and TG Therapeutics, Inc. have shown contrasting trajectories. Bausch Health, with a steady revenue stream, peaked in 2015 with a 27% increase from the previous year, reaching its highest revenue. However, it faced fluctuations, ending 2023 with a modest 6% increase from 2014. In contrast, TG Therapeutics, Inc. started with minimal revenue, but by 2023, it experienced a staggering growth, increasing its revenue by over 150,000% from 2014. This remarkable rise highlights TG Therapeutics' aggressive expansion and market penetration. As we look to the future, these trends underscore the importance of strategic innovation and market adaptation in the pharmaceutical industry.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025